A Comprehensive Review on DNA Gyrase Inhibitors.
DNA gyrase inhibitors
antibacterial
anticancer
antimalarial
docking
fungal infections
Journal
Infectious disorders drug targets
ISSN: 2212-3989
Titre abrégé: Infect Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269158
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
07
2019
revised:
12
09
2019
accepted:
15
12
2019
pubmed:
29
10
2020
medline:
10
9
2021
entrez:
28
10
2020
Statut:
ppublish
Résumé
The newly emerging infectious organisms, the global crisis in antibiotic resistance, and the threat of bioterrorism create an urgent need to discover novel antimicrobial agents. In order to develop novel antimicrobial agents, the mechanism of infectious disease must be better understood. DNA Gyrase is a bacterial enzyme that plays an important role in the replication of DNA and transcription process. It is not present in higher eukaryotes making it a perfect target for developing new antibacterial agents. This review describes the role of DNA gyrase inhibitors in preventing various diseases. In this review, we outline the synthesis and pharmacological action of various novel DNA gyrase inhibitors. DNA gyrase inhibitors were used to treat tuberculosis, bacterial, fungal infections and malaria. DNA gyrase inhibitors mainly act by preventing the supercoiling of DNA strands..
Identifiants
pubmed: 33109068
pii: IDDT-EPUB-103399
doi: 10.2174/1871526520666200102110235
doi:
Substances chimiques
Anti-Bacterial Agents
0
Topoisomerase II Inhibitors
0
DNA Gyrase
EC 5.99.1.3
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
765-777Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.